Cadent Capital Advisors’s Eli Lilly LLY Stock Holding History

Cadent Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.85M	Buy	2,376 +487	+26%	+$498K	0.59%	45
2026 Q1	$1.74M	Buy	1,889 +92	+5%	+$93.3K	0.45%	54
2025 Q4	$1.93M	Buy	1,797 +1,231	+217%	+$1.18M	0.5%	49
2025 Q3	$432K	Buy	566 +91	+19%	+$67.7K	0.11%	123
2025 Q2	$370K	Hold	475	–	–	0.12%	110
2025 Q1	$392K	Hold	475	–	–	0.14%	93
2024 Q4	$367K	Hold	475	–	–	0.13%	99
2024 Q3	$420K	Sell	475 -89	-16%	-$80K	0.13%	92
2024 Q2	$511K	Buy	564 +76	+16%	+$60.8K	0.2%	71
2024 Q1	$380K	Hold	488	–	–	0.15%	78
2023 Q4	$284K	Buy	488 +11	+2%	+$6.42K	0.14%	89
2023 Q3	$256K	Buy	477 +1	+0.2%	+$515	0.11%	101
2023 Q2	$223K	Buy	+476	New	+$200K	0.13%	116

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Cadent Capital Advisors's LLY Position: Q2 2026 in Review

Cadent Capital Advisors increased its Eli Lilly (LLY) stake by 26% in Q2 2026, buying an estimated $498K and bringing the position to 2,376 shares worth $2.85M. The position accounts for 0.59% of the portfolio, ranked #45.

Cadent Capital Advisors first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 2,213 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Cadent Capital Advisors held 2,376 shares of Eli Lilly worth $2.85M as of Q2 2026.
Cadent Capital Advisors bought 487 Eli Lilly shares in Q2 2026, an estimated $498K.
Eli Lilly made up 0.59% of Cadent Capital Advisors's portfolio in Q2 2026, its #45 holding.
Cadent Capital Advisors first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
2,213 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cadent Capital Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.